Copenhagen-based Neumirna Therapeutics raised €20M in a Series A funding round co-led by Angelini Ventures and Invivo Partners to accelerate clinical trials for its RNA therapies targeting neurological diseases.
Amount Raised
€20 Million
Round Type
Series A
CopenhagenBiotechnologyHealth CareTherapeuticsPharmaceuticalInvestors
Description
Neumirna Therapeutics has successfully raised €20M in a Series A funding round to advance the development of RNA-based therapies for conditions such as drug-resistant epilepsy and Parkinson’s disease. The investment will facilitate clinical trials for their lead candidate, NMT.001, while also strengthening R&D efforts.
Quick answer
Neumirna Therapeutics raised €20 Million in a Series A round, dated January 13, 2025. Investors: Innovestor's Life Science Fund, Angelini Ventures and Invivo Partners. Neumirna Therapeutics is based in Copenhagen, Capital Region Of Denmark, Denmark.
- How much did Neumirna Therapeutics raise?
- Neumirna Therapeutics raised €20 Million in a Series A round on January 13, 2025.
- Who invested in Neumirna Therapeutics?
- Innovestor's Life Science Fund, Angelini Ventures and Invivo Partners are named as investors in this round.
- What does Neumirna Therapeutics do?
- Neumirna Therapeutics is a biotechnology company based in Copenhagen, Denmark, dedicated to developing RNA-based therapies for complex neurological diseases.
- Where is Neumirna Therapeutics based and how big is it?
- Neumirna Therapeutics is based in Copenhagen, Capital Region Of Denmark, Denmark.
Source: Fundz verified event record.
Who else raised in Therapeutics and Pharmaceutical around the same time
Companies in the same sectors as Neumirna Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Acasti raised $15M on February 10, 2025.
- NRx Pharmaceuticals raised $3.5M (Seed) on January 27, 2025.
- Windward Bio raised $200M (Series A) on January 10, 2025.
- Verdiva Bio raised $411M (Series A) on January 9, 2025.
- Os Therapies raised $6M (Post-IPO Equity) on December 31, 2024.
- Os Therapies raised $7.1M on December 31, 2024.
Who to call at Neumirna Therapeutics, and when
A new round usually means Neumirna Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Neumirna Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Neumirna Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Neumirna Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Neumirna Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Funding Insights
What this usually meansNeumirna Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.